A Phase 2 Open-Label Study of the Pharmacokinetics and Safety of HTX-011 Administered Postpartum to Women Undergoing a Planned Caesarean Section)
Clinical Trial Grant
Administered By
Anesthesiology, Women's
Awarded By
Heron Therapeutics, Inc.
Start Date
January 11, 2021
End Date
July 27, 2022
Administered By
Anesthesiology, Women's
Awarded By
Heron Therapeutics, Inc.
Start Date
January 11, 2021
End Date
July 27, 2022